Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Rel Life Insurance launches two new products
Anil Dhirubhai Ambani Group firm Reliance Life Insurance today launched two new products -- Jan Samriddhi Plan and Super InvestAssure Plan here and aims to garner Rs 600 crore premium from them within this fiscal. http://smallpersonalloans.org.uk

Striking government
It wasn’t just ordinary passengers who suffered the brunt of the recent Air India strike. West Bengal Finance Minister Asim Dasgupta came to Delhi to attend a meeting on Goods and Service Tax (GST) with finance ministry officials. After which, he met Finance Minister Pranab Mukherjee. While Mukherjee’s office had kept an hour for the meeting, Dasgupta was in a hurry and spent just half the time since, with the Air India flight cancelled, he had no option but to leave on the earlier flight of a private airline.

News of the day

Government ups price, quota of levy sugar
Sugar prices, already at record highs, are set to rise further. The food ministry has decided to raise the levy price at which it buys sugar from mills to supply the public distribution system (PDS) by 50 per cent in Maharashtra and 63 per cent in Uttar Pradesh (UP) for the new sugar season starting next month. The two states account for 55 per cent of India’s sugar output. Prices have also been revised for other sugar purchasing states.
Small Business

Take Solutions in pact with South Korean firm

Take Solutions, an international business technology firm, today said it has entered into an agreement with South Korea-based IL-Yang Pharma Company Ltd for providing investigational new drug (IND) submission services to the company. - Four Soft puts merger with Take Solutions on hold - Fiat to position Grande Punto in premium small car segment - "Media-related issues will be taken up in transparent manner" - India Yamaha Motor sales rise 82.38% in May - India"s wireless user-base crosses 400-mn mark - Diesel ceases to earn profit for state oil firms The purpose of the IND submission is to gain Food and Drug Administration (FDA) non-objection to study the investigational agent in humans, Take Solutions said in a filing to the Bombay Stock Exchange. "Our reworked strategy toward focusing on the Asia Pacific region has received a major boost with IL-Yang Pharma," Take Solutions Vice President — sales, Life Sciences APAC, L Ramesh said. The IND submission must include, sufficient preclinical data, details of chemistry and description of mechanism of action of the agent, the filing added. Shares of Take Solutions were trading at Rs 38.30, up 8.50 per cent on the BSE.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009